You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

progesterone receptor modulator

Showing 1 - 25 of 8,628
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leiomyoma Trial run by the NICHD (ulipristal acetate 20 mg, ulipristal acetate 10 mg, )

Completed
Has Results
  • Leiomyoma
  • ulipristal acetate 20 mg
  • +2 more
  • Bethesda, Maryland
  • +1 more
Feb 14, 2022

Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 Trial in Stockholm (Mifepristone)

Completed
  • Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
  • Stockholm, Sweden
    Department of Woman and Child Health Karolinska University Hospi
Jan 15, 2022

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting
Has Results
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
Jun 8, 2022

Leiomyoma Trial run by the NICHD (CDB-2914)

Completed
  • Leiomyoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 13, 2023

Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

Recruiting
  • Carcinoma, Ovarian Epithelial
  • Low Grade Serous Adenocarcinoma of Ovary
  • Letrozole tablets
  • carboplatin AUC 5 and paclitaxel 175 mg/m2
  • Brescia, BS, Italy
  • +1 more
Oct 26, 2022

Urogenital Abnormalities Trial (CDB-2914)

Withdrawn
  • Urogenital Abnormalities
  • (no location specified)
Dec 14, 2019

Hyperandrogenism, Polycystic Ovary Syndrome, Puberty Trial in Charlottesville (Micronized progesterone, Spironolactone, Placebo)

Recruiting
  • Hyperandrogenism
  • +2 more
  • Micronized progesterone
  • +2 more
  • Charlottesville, Virginia
    University of Virginia Clinical Research Unit
May 16, 2022

Prostate Cancer Trial in Gainesville, Baltimore, Boston (LY2452473, Placebo)

Completed
Has Results
  • Prostate Cancer
  • Gainesville, Florida
  • +3 more
Sep 27, 2021

PCOS, Polycystic Ovary Syndrome Trial in Charlottesville (Micronized progesterone, Placebo, Flutamide)

Recruiting
  • PCOS
  • Polycystic Ovary Syndrome
  • Micronized progesterone
  • +3 more
  • Charlottesville, Virginia
    University of Virginia
May 16, 2022

Invasive Breast Cancer Trial in Madison ([18F]Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging)

Recruiting
  • Invasive Breast Cancer
  • [18F]Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging
  • Madison, Wisconsin
    University of Wisconsin, Madison
Dec 16, 2021

Missed Abortion, Anembryonic Pregnancy, Non-Viable Pregnancy Trial in Chapel Hill, Hillsborough (Ulipristal Acetate Tablets,

Recruiting
  • Missed Abortion
  • +2 more
  • Ulipristal Acetate Tablets
  • Misoprostol Pill
  • Chapel Hill, North Carolina
  • +3 more
Jun 9, 2022

Endometrial Tissues and Mononuclear Cells Receptivity in

Completed
  • Endometrial Hyperplasia Without Atypia
  • +6 more
  • endometrial tissue and peripheral blood mononuclear cells receptivity
  • (no location specified)
Oct 29, 2023

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative Trial in Duarte, Rancho Cucamonga, South Pasadena

Completed
Has Results
  • Estrogen Receptor Negative
  • +4 more
  • Duarte, California
  • +2 more
Jun 6, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

Active, not recruiting
  • Estrogen Receptor Positive
  • +3 more
  • Radiation Therapy
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 14, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +6 more
  • Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +8 more
Feb 3, 2022

Breast Cancer Trial in Phoenix, Zion, Nashville (Elacestrant, Onapristone)

Recruiting
  • Breast Cancer
  • Phoenix, Arizona
  • +2 more
Jan 20, 2023

Granulosa Cell Ovarian Cancer, Low Grade Serous Ovarian/ Primary Peritoneal Cancer, Endometrioid Endometrial Cancer Trial in

Recruiting
  • Granulosa Cell Ovarian Cancer
  • +2 more
  • Onapristone ER
  • Onapristone ER + Anastrozole
  • Basking Ridge, New Jersey
  • +7 more
Aug 17, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Breast Cancer Trial in Manchester (ulipristal acetate)

Active, not recruiting
  • Breast Cancer
  • ulipristal acetate
  • Manchester, United Kingdom
    University Hospitals of South Manchester
Jan 30, 2023

Clomiphene Citrate asInhibitor of Ovulation inOocyte

Not yet recruiting
  • Infertility, Female
  • Infertility
  • Baton Rouge, Louisiana
    Womans Hospital
May 17, 2023